Digital therapeutics are growing in popularity for patients. Combining science and technology creates a double-edge sword including one how to best establish quality and trust in the safety and efficacy of patients.
Maria Palombini, Director of Emerging Communities & Opportunities Development and Healthcare Life Sciences (HLS) Practice Lead at <a href='https://standards.ieee.org/?utm_source=podbean&utm_medium=post&utm_campaign=re-think-health-podcast'>IEEE Standards Association (IEEE SA)</a>, Michael Ambrose, Director of Product Quality and Analytical Process at USP about establishing standards in digital therapeutics to assure quality and build trust with patients -- the core of the healthcare ecosystem.
Related Resources:
<ul><li><a href='https://standards.ieee.org/practices/healthcare-life-sciences/index.html?utm_source=podbean&utm_medium=post&utm_campaign=re-think-health-podcast'>IEEE SA Healthcare and Life Sciences Practice Page</a></li>
<li><a href='https://qualitymatters.usp.org/sites/default/files/user-uploaded-files/USP_Digital_Therapeutics_Paper_2020-06-11.pdf'>White Paper: The Role of Public Standards in Assuring Quality of Digital Therapeutics</a></li>
</ul>

Contact Tracing Applications and Technologies Beyond COVID-19 – Re-Think Health

IEEE SA Voice shares insights and perspectives from the IEEE SA community, subject matter experts, and industry leaders that are working to raise the world's standards, drive market solutions, and much more, keeping you at the forefront of technological innovation for the benefit of humanity.